Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2072927
18404443
9085
10.1007/s11302-007-9085-8
Original Article


The role of ATP and adenosine in the brain under normoxic and ischemic conditions

Pedata
F.

+39-55-4271262
+39-55-4271280
felicita.pedata@unifi.it

1

Melani
A.

2

Pugliese
A. M.

1

Coppi
E.

1

Cipriani
S.

1

Traini
C.

1

1
Department of Preclinical and Clinical Pharmacology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy 
2
IRCCS Centro Neurolesi Bonino-Pulejo, Messina, Italy 

11
10
2007

9
2007

3
4
299
310
30
5
2007

25
9
2007


© Springer Science+Business Media B.V. 2007

1
1
2A
3
2A
2A
3
 receptor antagonism may be protective after ischemia is also reported.

Keywords
Adenosine
2A
 receptors
ATP
Ecto-ATPase inhibitors
Ischemia
P2 purinergic receptors

issue-copyright-statement
© Springer Science+Business Media B.V. 2007




Historical overview
1
2
1
2A
2B
3
3
4
5
6
]).

Roles of ATP in neurotransmission under normoxic conditions
7
8
1
7
9
1
10
11
1
3
12
14
].
15
11
16
17
18
Ki
19
Ki
20
1
Fig. 1a, b
a
 point
b
 Columns
P
P
15
])




21
25
26
2
15
3
27
Fig. 2
n
 Upper panels
 represent single traces recorded in a typical experiment before, during and after ATPγS application at different concentrations



Fig. 3
 Bars
P
 t
15
])





Roles of ATP in ischemic conditions
28
29
2+
7
1
15
15
30
33
34
34
35
36
37
7
7
7
36
].
38
1
12
12
39
40
].
41
43
44
2+
45
2+
2+
4
46
Fig. 4a, b
a
n
t
P
b
 column bar
n
t
P
P
46
])




47
29
].

Role of adenosine in cerebral transmission under normoxic conditions
1
48
49
1
1
2+
50
51
52
1
53
54
55
1
56
1
57
58
1
59
59
60
1
1
61
].
1
2A
62
64
2A
2+
65
66
2A
1
9
67
2A
1
68
69
2A
2A
70
72
].
2A
2A
59
2A
2
2A
2
2A
73
74
2A
 antagonists not only provide symptomatic relief but also decelerate dopaminergic neurone degeneration in patients.
3
3
75
3
3
1
8
3
76
3
2+
77
3
78
3
79
].
3
80
1
3
3
3
8
81
3
82
85
]).

Role of adenosine in ischemic conditions
82
86
87
5
88
Fig. 5
 ADP
 AMP
 ATP
 e5′-NT
5′-NT
 NTDPase
 P1
 P2
 SAH
 T
142
])




89
90
91
92
93
].
84
88
1
2+
55
94
95
+
−
96
97
98
] are protective in ischemia.
1
99
100
1
1
101
102
1
103
1
 receptor desensitization.
1
1
104
105
1
106
].
2A
107
2A
2A
2A
108
83
109
110
111
2A
2A
112
2A
83
110
113
2A 
59
70
71
114
115
2A
116
117
118
2A
119
2A
120
2A
 antagonists in brain ischemia may be largely due to reduced glutamate outflow from neurones and glial cells.
2A
2A
111
121
122
123
124
83
2A
125
2A
2A
126
2A
2A
127
2A
 antagonists may be attributed to inhibition of inflammation product production.
2A
128
129
130
2A
2A
131
2A
2A
89
2A
132
133
].
2A
134
], therefore inhibition of its rephosphorylation to ATP by adenosine kinase inhibitors does not weigh upon the ATP content.
3
3
81
3
3
135
3
136
3
136
3
3
137
138
].
139
3
3
1
3
140
141
3
135
3
1
3
 receptor-mediated effects from protective to injurious.
3
 receptor stimulation on synaptic transmission during hypoxic/ischemic phenomena depends on the intensity and duration of stimulation.

Concluding remarks
Purinergic signalling, e.g. adenosine and ATP, by activating specific membrane receptors (P1 and P2 respectively), is strictly correlated in orchestrating brain cell functions either under physiological normoxic or ischemic circumstances. However, the respective contribution of each single element is hard to discern from the total outcome, due to the rapid and ubiquitous enzymatic interconversion of these molecules.
1
 receptor activation) is well documented. Conversely our data, in line with previous observations in the literature, suggest that tonic activation of P2 receptors contributes to excitatory transmission in the hippocampus. Such an effect is modest, but it is unmasked by the application of P2 purinergic antagonists that reduce evoked synaptic responses.
1
 receptors. However, our evidence demonstrates that ATP itself may inhibit hippocampal synaptic transmission since an even more pronounced effect is observed when enzymatic ATP degradation is blocked. Moreover, in our studies in the hippocampus, a potentiation of neurotransmission by the ATP analogue, ATPγS, develops a few minutes after the inhibitory effect has been washed out, and it persists for 45 min to 1 h. Within the brain, ATP is involved in the synaptic plasticity phenomenon and may be an important mediator of long-lasting effects in synaptic plasticity.
1
2A
3
 receptors may be deleterious. The role of endogenously released ATP during cerebral ischemia is mainly deleterious, as found in our work and in the literature, since the application of P2 antagonists always results in a reduction in ischemic damage. The mechanisms underlying these effects are still unknown, but they can be correlated to the tonic excitatory action of endogenous ATP found in many brain regions (for example in the hippocampus and prefrontal cortex).
Purinergic signalling has an ancient phylogenetic origin. Expression of P2 receptors on cell membrane and responses to extracellular ATP are found in primitive prokaryotic species up to evolved animals and plants, suggesting an important and highly conserved role of extracellular purine nucleotides during evolution. Similarly, ontogenetic development in several species seems to involve purinergic signalling, especially during its first stages. Our observation that hMSCs, an undifferentiated line of cells able to originate a number of different cell lineages (adipocytes, chondrocytes, osteoblasts, neurones), spontaneously release ATP into the extracellular space and express functional purinergic P2 receptors, which modulate different kinds of membrane currents, and that ATP, during the early stages of culture, inhibits proliferation indicates an autocrine/paracrine mechanism of action for extracellular ATP in modulating cell functions of undifferentiated stem cells at early developmental stages. Such effects may be important in brain neurogenesis during development and in responses to neurodegenerative stimuli.


Acknowledgements
The present work was supported by Fondazione Monte dei Paschi of Siena, Siena, Italy.

References
1.
Burnstock
G

Dumsday
B

Smythe
A


Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide
Br J Pharmacol
1972
44
451
461

4339250


2.
Burnstock
G

Cocks
T

Kasakov
L



Direct evidence for ATP release from non-adrenergic, non-cholinergic (“purinergic”) nerves in the guinea-pig taenia coli and bladder
Eur J Pharmacol
1978
49
145
149

658131


3.
Fredholm
BB

IJzerman
AP

Jacobson
KA



International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
Pharmacol Rev
2001
53
527
552

11734617


4.
Abbracchio
MP

Burnstock
G


Purinoceptors: are there families of P2X and P2Y purinoceptors?
Pharmacol Ther
1994
64
445
475

7724657


5.
North
RA


Molecular physiology of P2X receptors
Physiol Rev
2002
82
1013
1067

12270951


6.
Ciana
P

Fumagalli
M

Trincavelli
ML



The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor
EMBO J
2006
25
4615
4627

16990797


7.
Cunha
RA

Sebastiao
AM

Ribeiro
JA


Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors
J Neurosci
1998
18
1987
1995

9482785


8.
Dunwiddie
TV

Diao
L

Proctor
WR


Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus
J Neurosci
1997
17
7673
7682

9315889


9.
O’Kane
EM

Stone
TW


Interaction between adenosine A1 and A2 receptor-mediated responses in the rat hippocampus in vitro
Eur J Pharmacol
1998
362
17
25

9865525


10.
Masino
SA

Diao
L

Illes
P



Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine A1 receptors
J Pharmacol Exp Ther
2002
303
356
363

12235271


11.
Zimmermann
H

Braun
N


Extracellular metabolism of nucleotides in the nervous system
J Auton Pharmacol
1996
16
397
400

9131425


12.
Rodrigues
RJ

Almeida
T

Richardson
PJ



Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus
J Neurosci
2005
25
6286
6295

16000618


13.
Mendoza-Fernandez
V

Andrew
RD

Barajas-Lopez
C


ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices
J Pharmacol Exp Ther
2000
293
172
179

10734167


14.
Luthardt
J

Borvendeg
SJ

Sperlagh
B



P2Y(1) receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex
Neurochem Int
2003
42
161
172

12421596


15.
Coppi
E

Pugliese
AM

Stephan
H



Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices
Purinergic Signalling
2007
3
203

Coppi E, Pugliese AM, Stephan H et al (2007) Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices. Purinergic Signalling 3:203 

16.
Zimmermann
H

Braun
N

Kegel
B



New insights into molecular structure and function of ectonucleotidases in the nervous system
Neurochem Int
1998
32
421
425

9676740


17.
Zimmermann
H


Extracellular metabolism of ATP and other nucleotides
Naunyn Schmiedebergs Arch Pharmacol
2000
362
299
309

11111825


18.
Iqbal
J

Vollmayer
P

Braun
N



A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDase) and the analysis of inhibitors by in-capillary enzymatic microreaction
Purinergic Signalling
2007
1
349
358

Iqbal J, Vollmayer P, Braun N et al (2007) A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDase) and the analysis of inhibitors by in-capillary enzymatic microreaction. Purinergic Signalling 1:349–358 

19.
Kukulski
F

Komoszynski
M


Purification and characterization of NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from porcine brain cortex synaptosomes
Eur J Biochem
2003
270
3447
3454

12899702


20.
Muller
CE

Iqbal
J

Baqi
Y



Polyoxometalates-a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors
Bioorg Med Chem Lett
2006
16
5943
5947

16997558


21.
Wieraszko
A

Seyfried
TN


ATP-induced synaptic potentiation in hippocampal slices
Brain Res
1989
491
356
359

2765890


22.
Fujii
S

Kato
H

Furuse
H



The mechanism of ATP-induced long-term potentiation involves extracellular phosphorylation of membrane proteins in guinea-pig hippocampal CA1 neurons
Neurosci Lett
1995
187
130
132

7783959


23.
Fujii
S

Kato
H

Kuroda
Y


Extracellular adenosine 5′-triphosphate plus activation of glutamatergic receptors induces long-term potentiation in CA1 neurons of guinea pig hippocampal slices
Neurosci Lett
1999
276
21
24

10586965


24.
Fujii
S

Kato
H

Kuroda
Y


Cooperativity between extracellular adenosine 5′-triphosphate and activation of N-methyl-D-aspartate receptors in long-term potentiation induction in hippocampal CA1 neurons
Neuroscience
2002
113
617
628

12150781


25.
O’Kane
EM

Stone
TW


Characterisation of ATP-induced facilitation of transmission in rat hippocampus
Eur J Pharmacol
2000
409
159
166

11104829


26.
Abrams
TW

Kandel
ER


Is contiguity detection in classical conditioning a system or a cellular property? Learning in Aplysia suggests a possible molecular site
Trends Neurosci
1988
11
128
135

2469180


27.
Pankratov
Y

Castro
E

Miras-Portugal
MT



A purinergic component of the excitatory postsynaptic current mediated by P2X receptors in the CA1 neurons of the rat hippocampus
Eur J Neurosci
1998
10
3898
3902

9875366


28.
Juranyi
Z

Sperlagh
B

Vizi
ES


Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices
Brain Res
1999
823
183
190

10095025


29.
Melani
A

Turchi
D

Vannucchi
MG



ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia
Neurochem Int
2005
47
442
448

16029911


30.
Amadio
S

D’Ambrosi
N

Cavaliere
F



P2 receptor modulation and cytotoxic function in cultured CNS neurons
Neuropharmacology
2002
42
489
501

11955520


31.
Cavaliere
F

D’Ambrosi
N

Ciotti
MT



Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists
Neurochem Int
2001
38
189
197

11099776


32.
Volonte
C

Merlo
D


Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons
J Neurosci Res
1996
45
183
193

8843035


33.
Volonte
C

Ciotti
MT

D’Ambrosi
N



Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones
Neuropharmacology
1999
38
1335
1342

10471087


34.
Ryu
JK

Kim
J

Choi
SH



ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors
Neuroreport
2002
13
1611
1615

12352612


35.
Kharlamov
A

Jones
SC

Kim
DK


Suramin reduces infarct volume in a model of focal brain ischemia in rats
Exp Brain Res
2002
147
353
359

12428143


36.
Melani
A

Amadio
S

Gianfriddo
M



P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat
J Cereb Blood Flow Metab
2006
26
974
982

16395292


37.
Lammer
A

Gunther
A

Beck
A



Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats
Eur J Neurosci
2006
23
2824
2828

16817887


38.
Marrelli
SP

Khorovets
A

Johnson
TD



P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion
Am J Physiol
1999
276
H33
H41

9887014


39.
Lahiri
P

Chaudhuri
U

Chattopadhyay
A



Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events
Blood Cells Mol Dis
2005
34
248
256

15885609


40.
Ziegler
S

Schillinger
M

Funk
M



Association of a functional polymorphism in the clopidogrel target receptor gene, P2Y12, and the risk for ischemic cerebrovascular events in patients with peripheral artery disease
Stroke
2005
36
1394
1399

15933261


41.
Neary
JT


Trophic actions of extracellular ATP: gene expression profiling by DNA array analysis
J Auton Nerv Syst
2000
81
200
204

10869721


42.
Rathbone
MP

DeForge
S

Deluca
B



Purinergic stimulation of cell division and differentiation: mechanisms and pharmacological implications
Med Hypotheses
1992
37
213
219

1625596


43.
Franke
H

Illes
P


Involvement of P2 receptors in the growth and survival of neurons in the CNS
Pharmacol Ther
2006
109
297
324

16102837


44.
Mishrda
SK

Braun
N

Shukla
V



Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation
Development
2006
133
675
684

16436623


45.
Kawano
S

Otsu
K

Kuruma
A



ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells
Cell Calcium
2006
39
313
324

16445977


46.
Coppi E, Pugliese AM, Urbani S et al (2007) ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells 25:1840–1849

47.
Scholzke MN, Schwaninger M (2007) Transcriptional regulation of neurogenesis: potential mechanisms in cerebral ischemia. J Mol Med 85:577–588

48.
Latini
S

Pedata
F


Adenosine in the central nervous system: release mechanisms and extracellular concentrations
J Neurochem
2001
79
463
484

11701750


49.
Lubitz
DK

Lin
RC

Bischofberger
N



Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist
Eur J Pharmacol
1999
369
313
317

10225368


50.
Yawo
H

Chuhma
N


Preferential inhibition of omega-conotoxin-sensitive presynaptic Ca2+ channels by adenosine autoreceptors
Nature
1993
365
256
258

8396730


51.
Wu
LG

Saggau
P


Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus
Neuron
1994
12
1139
1148

8185949


52.
Prince
DA

Stevens
CF


Adenosine decreases neurotransmitter release at central synapses
Proc Natl Acad Sci USA
1992
89
8586
8590

1382294


53.
Fredholm
BB

Dunwiddie
TV


How does adenosine inhibit transmitter release?
Trends Pharmacol Sci
1988
9
130
134

2907698


54.
Burke
SP

Nadler
JV


Regulation of glutamate and aspartate release from slices of the hippocampal CA1 area: effects of adenosine and baclofen
J Neurochem
1988
51
1541
1551

2902197


55.
Corradetti
R

Lo
CG

Moroni
F



Adenosine decreases aspartate and glutamate release from rat hippocampal slices
Eur J Pharmacol
1984
104
19
26

6149943


56.
Lupica
CR

Proctor
WR

Dunwiddie
TV


Presynaptic inhibition of excitatory synaptic transmission by adenosine in rat hippocampus: analysis of unitary EPSP variance measured by whole-cell recording
J Neurosci
1992
12
3753
3764

1328558


57.
Takigawa
T

Alzheimer
C


G protein-activated inwardly rectifying K+ (GIRK) currents in dendrites of rat neocortical pyramidal cells
J Physiol
1999
517
Pt 2
385
390

10332089


58.
Takigawa
T

Alzheimer
C


Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells
J Physiol
2002
539
67
75

11850502


59.
Latini
S

Bordoni
F

Corradetti
R



Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices
Br J Pharmacol
1999
128
1035
1044

10556941


60.
Latini
S

Bordoni
F

Pedata
F



Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices
Br J Pharmacol
1999
127
729
739

10401564


61.
Moore
KA

Nicoll
RA

Schmitz
D


Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses
Proc Natl Acad Sci USA
2003
100
14397
14402

14608033


62.
Pedata
F

Pepeu
G

Spignoli
G


Biphasic effect of methylxanthines on acetylcholine release from electrically-stimulated brain slices
Br J Pharmacol
1984
83
69
73

6487897


63.
Latini
S

Pazzagli
M

Pepeu
G



A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system
Gen Pharmacol
1996
27
925
933

8909972


64.
Sebastiao
AM

Ribeiro
JA


Adenosine A2 receptor-mediated excitatory actions on the nervous system
Prog Neurobiol
1996
48
167
189

8735876


65.
Spignoli
G

Pedata
F

Pepeu
G


A1 and A2 adenosine receptors modulate acetylcholine release from brain slices
Eur J Pharmacol
1984
97
341
342

6323196


66.
Cunha
RA

Johansson
B

Fredholm
BB



Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus
Neurosci Lett
1995
196
41
44

7501252


67.
Cunha
RA

Johansson
B

Ploeg
I



Evidence for functionally important adenosine A2a receptors in the rat hippocampus
Brain Res
1994
649
208
216

7953635


68.
Dixon
AK

Widdowson
L

Richardson
PJ


Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum
J Neurochem
1997
69
315
321

9202325


69.
Stone TW, Nikbakth M-R, O’Kane EM (2004) Adenosine and purines. In: Riedel G, Platt B (eds) From messengers to molecules: memories are made of these. Kluwer Academic/Plenum, New York, p 196–223

70.
Popoli
P

Betto
P

Reggio
R



Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats
Eur J Pharmacol
1995
287
215
217

8749040


71.
Corsi
C

Melani
A

Bianchi
L



2A
+
-evoked glutamate release in vivo in young and aged rats
Neuroreport
1999
10
687
691

10208531


72.
Corsi
C

Melani
A

Bianchi
L



Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats
Neuroreport
2000
11
2591
2595

10943728


73.
Ross
GW

Abbott
RD

Petrovitch
H



Association of coffee and caffeine intake with the risk of Parkinson disease
JAMA
2000
283
2674
2679

10819950


74.
Ascherio
A

Zhang
SM

Hernan
MA



Prospective study of caffeine consumption and risk of Parkinson’s disease in men and women
Ann Neurol
2001
50
56
63

11456310


75.
Costenla
AR

Lopes
LV

de Mendonca
A



A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus
Neurosci Lett
2001
302
53
57

11278110


76.
Macek
TA

Schaffhauser
H

Conn
PJ


Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins
J Neurosci
1998
18
6138
6146

9698308


77.
Fleming
KM

Mogul
DJ


Adenosine A3 receptors potentiate hippocampal calcium current by a PKA-dependent/PKC-independent pathway
Neuropharmacology
1997
36
353
362

9175614


78.
Laudadio
MA

Psarropoulou
C


The A3 adenosine receptor agonist 2-Cl-IB-MECA facilitates epileptiform discharges in the CA3 area of immature rat hippocampal slices
Epilepsy Res
2004
59
83
94

15246113


79.
Etherington
LA

Frenguelli
BG


Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner
Eur J Neurosci
2004
19
2539
2550

15128407


80.
Brand
A

Vissiennon
Z

Eschke
D



Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons
Neuropharmacology
2001
40
85
95

11077074


81.
Pugliese
AM

Latini
S

Corradetti
R



Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors
Br J Pharmacol
2003
140
305
314

12970092


82.
Melani
A

Pantoni
L

Corsi
C



Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage
Stroke
1999
30
2448
2454

10548683


83.
Melani
A

Pantoni
L

Bordoni
F



The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat
Brain Res
2003
959
243
250

12493612


84.
Latini
S

Bordoni
F

Corradetti
R



Temporal correlation between adenosine outflow and synaptic potential inhibition in rat hippocampal slices during ischemia-like conditions
Brain Res
1998
794
325
328

9622666


85.
Pearson
T

Damian
K

Lynas
RE



Sustained elevation of extracellular adenosine and activation of A1 receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro
J Neurochem
2006
97
1357
1368

16696848


86.
Dux
E

Fastbom
J

Ungerstedt
U



Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus
Brain Res
1990
516
248
256

2364291


87.
Phillis
JW

Smith-Barbour
M

O’Regan
MH



Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion
Neurochem Res
1994
19
1125
1130

7824064


88.
Frenguelli
BG

Wigmore
G

Llaudet
E



Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus
J Neurochem
2007
101
1400
1413

17459147


89.
Phillis
JW

O’Regan
MH


Deoxycoformycin antagonizes ischemia-induced neuronal degeneration
Brain Res Bull
1989
22
537
540

2785431


90.
Lin
Y

Phillis
JW


Deoxycoformycin and oxypurinol: protection against focal ischemic brain injury in the rat
Brain Res
1992
571
272
280

1611498


91.
DeLeo
J

Schubert
P

Kreutzberg
GW


Protection against ischemic brain damage using propentofylline in gerbils
Stroke
1988
19
1535
1539

3201513


92.
Parkinson
FE

Xiong
W

Zamzow
CR


Astrocytes and neurons: different roles in regulating adenosine levels
Neurol Res
2005
27
153
160

15829178


93.
Kitagawa
H

Mori
A

Shimada
J



Intracerebral adenosine infusion improves neurological outcome after transient focal ischemia in rats
Neurol Res
2002
24
317
323

11958429


94.
Pedata
F

Latini
S

Pugliese
AM



Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions
J Neurochem
1993
61
284
289

8515275


95.
Choi
DW


Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists
Stroke
1990
21
III20
III22

2146778


96.
Greene
RW

Haas
HL


The electrophysiology of adenosine in the mammalian central nervous system
Prog Neurobiol
1991
36
329
341

1678539


97.
Tominaga
K

Shibata
S

Watanabe
S


A neuroprotective effect of adenosine A1-receptor agonists on ischemia-induced decrease in 2-deoxyglucose uptake in rat hippocampal slices
Neurosci Lett
1992
145
67
70

1461571


98.
Gourine
AV

Dale
N

Gourine
VN



Fever in systemic inflammation: roles of purines
Front Biosci
2004
9
1011
1022

14766427


99.
Lubitz
DK


Adenosine in the treatment of stroke: yes, maybe, or absolutely not?
Expert Opin Invest Drugs
2001
10
619
632

von Lubitz DK (2001) Adenosine in the treatment of stroke: yes, maybe, or absolutely not? Expert Opin Invest Drugs 10:619–632 

100.
Pearson
T

Currie
AJ

Etherington
LA



Plasticity of purine release during cerebral ischemia: clinical implications?
J Cell Mol Med
2003
7
362
375

14754505


101.
Jarrott
DM

Domer
FR


A gerbil model of cerebral ischemia suitable for drug evaluation
Stroke
1980
11
203
209

6989034


102.
Rudolphi
KA

Keil
M

Fastbom
J



Ischaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment
Neurosci Lett
1989
103
275
280

2812514


103.
Jacobson
KA

Lubitz
DK

Daly
JW



Adenosine receptor ligands: differences with acute versus chronic treatment
Trends Pharmacol Sci
1996
17
108
113

8936347


104.
Williams
M


Purinergic drugs: opportunities in the 1990s
Drug Dev Res
1993
28
438

Williams M (1993) Purinergic drugs: opportunities in the 1990s. Drug Dev Res 28:438 

105.
Lubitz
DK

Lin
RC

Paul
IA



Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils
Eur J Pharmacol
1996
316
171
179

8982684


106.
Phillis
JW

Goshgarian
HG


Adenosine and neurotrauma: therapeutic perspectives
Neurol Res
2001
23
183
189

11320597


107.
Gao
Y

Phillis
JW


CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil
Life Sci
1994
55
L61
L65

Gao Y, Phillis JW (1994) CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil. Life Sci 55:L61–L65 

108.
Bona
E

Aden
U

Gilland
E



Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists
Neuropharmacology
1997
36
1327
1338

9364488


109.
Monopoli
A

Lozza
G

Forlani
A



Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats
Neuroreport
1998
9
3955
3959

9875735


110.
Pedata
F

Gianfriddo
M

Turchi
D



The protective effect of adenosine A2A receptor antagonism in cerebral ischemia
Neurol Res
2005
27
169
174

15829180


111.
Melani
A

Gianfriddo
M

Vannucchi
MG



The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia
Brain Res
2006
1073–1074
470
480

16443200


112.
Chen
JF

Huang
Z

Ma
J



A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice
J Neurosci
1999
19
9192
9200

10531422


113.
Marcoli
M

Raiteri
L

Bonfanti
A



Sensitivity to selective adenosine A1 and A2A receptor antagonists of the release of glutamate induced by ischemia in rat cerebrocortical slices
Neuropharmacology
2003
45
201
210

12842126


114.
O’Regan
MH

Simpson
RE

Perkins
LM



The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex
Neurosci Lett
1992
138
169
172

1357597


115.
Simpson
RE

O’Regan
MH

Perkins
LM



Excitatory transmitter amino acid release from the ischemic rat cerebral cortex: effects of adenosine receptor agonists and antagonists
J Neurochem
1992
58
1683
1690

1348522


116.
Fiebich
BL

Biber
K

Lieb
K



Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2A-receptors
Glia
1996
18
152
160

8913778


117.
Saura
J

Angulo
E

Ejarque
A



Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia
J Neurochem
2005
95
919
929

16092928


118.
Lee
YC

Chien
CL

Sun
CN



Characterization of the rat A2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system
Eur J Neurosci
2003
18
1786
1796

14622213


119.
Nishizaki
T

Nagai
K

Nomura
T



A new neuromodulatory pathway with a glial contribution mediated via A2A adenosine receptors
Glia
2002
39
133
147

12112365


120.
Pintor
A

Galluzzo
M

Grieco
R



Adenosine A2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors
J Neurochem
2004
89
152
156

15030399


121.
Irving
EA

Barone
FC

Reith
AD



Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat
Brain Res Mol Brain Res
2000
77
65
75

10814833


122.
Wu
DC

Ye
W

Che
XM



Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain
J Cereb Blood Flow Metab
2000
20
1320
1330

10994854


123.
Barone
FC

Irving
EA

Ray
AM



Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia
Med Res Rev
2001
21
129
145

11223862


124.
Gao
Y

Signore
AP

Yin
W



Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway
J Cereb Blood Flow Metab
2005
25
694
712

15716857


125.
Kawasaki
H

Morooka
T

Shimohama
S



Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells
J Biol Chem
1997
272
18518
18521

9228012


126.
Trincavelli ML, Melani A, Guidi S et al (2007) Regulation of A2A adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J Neurochem. DOI 10.1111/j.1471-4159.2007.04990.x

127.
Yu
L

Huang
Z

Mariani
J



Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury
Nat Med
2004
10
1081
1087

15448683


128.
Sheardown
MJ

Knutsen
LJS


Unexpected neuroprotection observed with the adenosine A2A receptor agonist cgs 21680
Drug Dev Res
1996
39
108

Sheardown MJ, Knutsen LJS (1996) Unexpected neuroprotection observed with the adenosine A2A receptor agonist cgs 21680. Drug Dev Res 39:108 

129.
Lubitz
DK

Lin
RC

Jacobson
KA


Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist
Eur J Pharmacol
1995
287
295
302

8991804


130.
Jones
PA

Smith
RA

Stone
TW


Protection against kainate-induced excitotoxicity by adenosine A2A receptor agonists and antagonists
Neuroscience
1998
85
229
237

9607714


131.
Jones
PA

Smith
RA

Stone
TW


Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist
Brain Res
1998
800
328
335

9685693


132.
Sitkovsky
MV

Ohta
A


The ‘danger’ sensors that STOP the immune response: the A2 adenosine receptors?
Trends Immunol
2005
26
299
304

15922945


133.
Mayne
M

Fotheringham
J

Yan
HJ



Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage
Ann Neurol
2001
49
727
735

11409424


134.
Latini
S

Corsi
C

Pedata
F



The source of brain adenosine outflow during ischemia and electrical stimulation
Neurochem Int
1995
27
239
244

8520462


135.
Pugliese
AM

Coppi
E

Spalluto
G



A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro
Br J Pharmacol
2006
147
524
532

16415905


136.
Lubitz
DK

Lin
RC

Popik
P



Adenosine A3 receptor stimulation and cerebral ischemia
Eur J Pharmacol
1994
263
59
67

7821362


137.
Palmer
TM

Benovic
JL

Stiles
GL


Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase-mediated mechanism
J Biol Chem
1995
270
29607
29613

7494005


138.
Trincavelli
ML

Tuscano
D

Marroni
M



A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation
Mol Pharmacol
2002
62
1373
1384

12435805


139.
Hentschel
S

Lewerenz
A

Nieber
K


Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons
Restor Neurol Neurosci
2003
21
55
63

12808203


140.
Fedorova
IM

Jacobson
MA

Basile
A



Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration
Cell Mol Neurobiol
2003
23
431
447

12825837


141.
Chen
GJ

Harvey
BK

Shen
H



Activation of adenosine A3 receptors reduces ischemic brain injury in rodents
J Neurosci Res
2006
84
1848
1855

17016854


142.
Pedata
F

Pugliese
AM

Coppi
E



Adenosine in the central nervous system: effects on neurotransmission and neuroprotection
Immunol Endocr Metab Agents Med Chem
2007
7
304
321

Pedata F, Pugliese AM, Coppi E et al (2007) Adenosine in the central nervous system: effects on neurotransmission and neuroprotection. Immunol Endocr Metab Agents Med Chem 7:304–321 




